Andrea Martinez

Andrea Martinez

Auto-generated profile, based on publicly available information

Andrea Martinez

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in US Cardiology Review
Verified
Journal Article
Open access
PDF file
AMAndrea Martinez
Andrea Martinez
JHJingwen Huang
Jingwen Huang
AHArash Harzand
Arash Harzand
Peripheral artery disease (PAD) is an atherosclerotic disease associated with significant functional impairment, morbidity, and mortality. Among women, PAD remains poorly recognized and undermanaged. Compared with men, women with PAD tend to be underdiagnosed or misdiagnosed, have poorer quality of life, and experience higher rates of PAD-related morbidity and cardiovascular mortality. In this review, we describe the sex- and gender-related differences in the epidemiology, presentation, diagnosis, and management of PAD. We provide specific recommendations to overcome these factors, including greater awareness and an increased emphasis on tailored and more aggressive interventions for women with PAD. Such changes are warranted and necessary to achieve more equitable outcomes in women with PAD, including improved limb outcomes, enhanced lifestyle, and cardiovascular risk reduction.

21 July 2025 in JACC
Verified
Journal Article
Closed access
AMAndrea Martinez
Andrea Martinez
MEMuhammad Etiwy
Muhammad Etiwy
JJJames L. Januzzi
James L. Januzzi
CMCian P. McCarthy
Cian P. McCarthy
DCDavid Cheng
David Cheng
JWJason H. Wasfy
Jason H. Wasfy

11 February 2023 in medRxiv
Verified
Preprint
Open access
PDF file
AMAndrea Martinez
Andrea Martinez
AOAlexis Okoh
Alexis Okoh
YKYi-An Ko
Yi-An Ko
BWBryan Wells
Bryan Wells
Background Fibromuscular dysplasia (FMD) is a non-atherosclerotic arteriopathy associated with stenosis, aneurysm, and dissection. We aimed to characterize racial differences in clinical presentation and diagnosis among patients with FMD at our institution. Methods We utilized an ambulatory FMD database to review demographics, clinical presentation, and diagnostic assessments of patients diagnosed with FMD within a university-affiliated healthcare system. Patients were classified as White or Non-White based on self-identified race. We evaluated race-specific differences in diagnosis and disease manifestations. Results A total of 208 patients (White: n=160 (77%); Non-White; n=48 (23%)) were included in the analysis. The time from initial FMD symptom to diagnosis was longer in Non-Whites than Whites (5.5 vs. 1.5 yrs; p<0.001), yet time from diagnosis to Emory specialist center visit was longer in Whites (3.2 vs. 1.2 yrs; p=0.035). Whites were more likely to undergo ≥ 5 multi-imaging diagnostic assessments than Non-Whites (89% vs. 73%; p=0.002). History of hypertension, stroke, & chronic kidney disease were more common in Non-Whites. FMD involvement of the internal carotid artery and upper extremity vessels were more common in Non-Whites, while Whites had more renal artery involvement. Conclusion We found racial differences in the diagnosis of FMD. The time from symptom onset to diagnosis was longer in Non-White than White FMD patients. Multimodality diagnostic imaging was more often utilized in Whites than Non-Whites. Research is needed to investigate these racial differences.

30 April 2024 in Vascular Medicine
Verified
Journal Article
Closed access
AMAndrea Martinez
Andrea Martinez
RSRebecca S Steinberg
Rebecca S Steinberg
AOAlexis Okoh
Alexis Okoh
YKYi-An Ko
Yi-An Ko
BWBryan Wells
Bryan Wells